APA

Frelinger A. L., Jakubowski J. A., Li Y., Barnard M. R., Fox M. L., Linden M. D., Sugidachi A., Winters K. J., Furman M. I. & Michelson A. D. (20070905). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. : Thrombosis and haemostasis.

Chicago

Frelinger Andrew L, Jakubowski Joseph A, Li Youfu, Barnard Marc R, Fox Marsha L, Linden Matthew D, Sugidachi Atsuhiro, Winters Kenneth J, Furman Mark I and Michelson Alan D. 20070905. The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. : Thrombosis and haemostasis.

Harvard

Frelinger A. L., Jakubowski J. A., Li Y., Barnard M. R., Fox M. L., Linden M. D., Sugidachi A., Winters K. J., Furman M. I. and Michelson A. D. (20070905). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. : Thrombosis and haemostasis.

MLA

Frelinger Andrew L, Jakubowski Joseph A, Li Youfu, Barnard Marc R, Fox Marsha L, Linden Matthew D, Sugidachi Atsuhiro, Winters Kenneth J, Furman Mark I and Michelson Alan D. The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. : Thrombosis and haemostasis. 20070905.